Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Organovo Holdings Inc (NYSE MKT LLC:ONVO)

3.64
Delayed Data
As of Jun 29
 +0.28 / +8.33%
Today’s Change
1.60
Today|||52-Week Range
4.13
+46.18%
Year-to-Date
Strong On High Relative Volume: Organovo Holdings (ONVO)
Jun 28 / TheStreet.com - Paid Partner Content
Organovo Isn't Worried About the Competition, But Should It Be?
Jun 27 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close3.36
Today’s open3.43
Day’s range3.33 - 3.73
Volume2,131,289
Average volume (3 months)663,464
Market cap$310.4M
Dividend yield--
Data as of 06/29/2016

Growth & Valuation

Earnings growth (last year)-13.16%
Earnings growth (this year)+1.16%
Earnings growth (next 5 years)--
Revenue growth (last year)+159.72%
P/E ratioNM
Price/Sales131.78
Price/Book4.99

Competitors

 Today’s
change
Today’s
% change
CGENCompugen Ltd-0.01-0.15%
VYGRVoyager Therapeutics...-0.18-1.67%
AGENAgenus Inc+0.09+2.32%
IMGNImmunoGen Inc-0.05-1.57%
Data as of 06/29/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$1.5M
Annual profit (last year)-$38.6M
Net profit margin-2,601.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Keith Murphy
Chief Scientific Officer
Sharon Collins Presnell
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs